This can be a short description about this vertical and all the great links contained therein.
R&D Strategy
Evidence
Pipeline
Clinical Trials
Article originally published February 2026 […]
Learn More ›
This can be a short description about this vertical and all the great links contained therein.
First-ever FDA authorized AI sepsis diagnostic tool with powerful diagnostic and predictive capabilities
5th World Sepsis Congress | […]
Learn More ›
This can be a short description about this vertical and all the great links contained therein.
Resource Library
Events
Sepsis ImmunoScore® demonstrates stronger predictive […]
Learn More ›
Read the latest Prenosis peer-reviewed articles and items from scholarly journals.
Newsroom
Sepsis ImmunoScore® demonstrates stronger predictive […]
Learn More ›
Read the latest Prenosis peer-reviewed articles and items from scholarly journals.
Mission, Vision, Values
Careers
Leadership
Awards
AI in Chicago | Episode […]
Learn More ›
Article originally published in Forbes on May 22, 2025
Prenosis featured in article by author Michael L. Millenson, covering innovations at the 2025 MedCity INVEST conference in Chicago.
“Treating artificial intelligence as just one ingredient in a business success recipe was a prominent theme at the MedCity INVEST 2025 conference, with this AI “best practice” advice epitomized by high-profile start-ups Inato and Prenosis.”